• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Dialkyl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Dialkyl ethers

Professional Introduction to O-(3-methoxypropyl)hydroxylamine (CAS No. 343925-88-2)

O-(3-methoxypropyl)hydroxylamine, a compound with the chemical identifier CAS No. 343925-88-2, is a significant molecule in the field of chemical and pharmaceutical research. This compound, characterized by its unique structural properties, has garnered attention for its potential applications in various biochemical and medicinal contexts.

The molecular structure of O-(3-methoxypropyl)hydroxylamine consists of a hydroxylamine group attached to a 3-methoxypropyl chain. This configuration imparts distinct reactivity and functionality, making it a valuable intermediate in synthetic chemistry. The presence of the hydroxylamine moiety suggests potential roles in redox reactions and nucleophilic substitutions, which are pivotal in drug development and biochemical pathways.

Recent advancements in the study of O-(3-methoxypropyl)hydroxylamine have highlighted its utility in the synthesis of bioactive molecules. Researchers have explored its incorporation into various pharmacophores, demonstrating its ability to enhance the efficacy of therapeutic agents. For instance, studies have shown that derivatives of this compound can modulate enzyme activity and interact with biological targets, offering promising avenues for developing novel treatments for neurological and inflammatory disorders.

In the realm of medicinal chemistry, the use of O-(3-methoxypropyl)hydroxylamine as a building block has led to the discovery of several novel compounds with therapeutic potential. Its ability to serve as a precursor for more complex molecules has been particularly useful in designing drugs that require specific stereochemical arrangements. This flexibility makes it an attractive candidate for further exploration in drug discovery pipelines.

The chemical reactivity of O-(3-methoxypropyl)hydroxylamine also makes it a valuable tool in synthetic organic chemistry. Its participation in various reaction mechanisms allows chemists to construct intricate molecular frameworks with precision. This has been particularly beneficial in the synthesis of complex natural products and artificial molecules designed for specific biological functions.

Moreover, the study of O-(3-methoxypropyl)hydroxylamine has provided insights into its role in biochemical pathways. Researchers have identified its involvement in processes that are critical for cellular homeostasis and disease mechanisms. By understanding how this compound interacts with biological systems, scientists can develop targeted interventions that address specific pathological conditions.

The pharmaceutical industry has taken note of the potential applications of O-(3-methoxypropyl)hydroxylamine and is actively investigating its use in drug development. Preclinical studies have demonstrated its efficacy in models of inflammation and neurodegeneration, paving the way for clinical trials. These trials aim to validate its therapeutic benefits and establish safe dosing regimens for human use.

As research continues to unfold, the applications of O-(3-methoxypropyl)hydroxylamine are expected to expand further. Its unique chemical properties make it a versatile tool for scientists working across multiple disciplines, from synthetic chemistry to pharmacology. The ongoing exploration of this compound promises to yield new insights and innovations that could revolutionize how we approach disease treatment and prevention.

In conclusion, O-(3-methoxypropyl)hydroxylamine (CAS No. 343925-88-2) represents a fascinating compound with broad implications in chemical research and pharmaceutical development. Its structural features, reactivity, and potential biological roles make it a cornerstone molecule worthy of continued investigation. As our understanding deepens, so too will the opportunities for leveraging this compound to advance medical science and improve human health.

• 2228887-50-9(O-(3-methoxy-2-methylpropyl)hydroxylamine)
• 1204333-51-6(O-[(oxetan-3-yl)methyl]hydroxylamine)
• 98627-69-1(Hydroxylamine, O,O'-1,3-propanediylbis-)
• 2145957-91-9(O-(3-methoxy-2,2-dimethylpropyl)hydroxylamine)
• 1564622-39-4(O-(4-methoxybutyl)hydroxylamine)
• 1858640-32-0(O-[3-(propan-2-yloxy)propyl]hydroxylamine)
• 343925-76-8(3-(aminooxy)propan-1-ol)
• 1496798-28-7(O-(3-ethoxypropyl)hydroxylamine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)